These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9892382)

  • 21. [Darbepoetin-alfa treatment of anemia secondary to chronic renal failure in dialysis patients: Results of a French multicenter study].
    Kessler M; Hannedouche T; Fitte H; Cayotte JL; Urena P; Réglier JC;
    Nephrol Ther; 2006 Sep; 2(4):191-9. PubMed ID: 16966064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correction of anemia in chronic kidney failure with lyophilized recombinant human erythropoietin using a subcutaneous approach].
    Amar M; Cendoroglo Neto M; Canziani ME; Nadaletto MA; Ajzen H; Draibe SA
    Rev Assoc Med Bras (1992); 1994; 40(2):101-7. PubMed ID: 7820145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.
    Watson AJ; Gimenez LF; Cotton S; Walser M; Spivak JL
    Am J Med; 1990 Oct; 89(4):432-5. PubMed ID: 2220877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human erythropoietin utilization in Department of Veterans Affairs dialysis units.
    Wolfson M; Mundt DJ; Hawley GG
    Am J Kidney Dis; 1994 Aug; 24(2):184-91. PubMed ID: 8048423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC; Lee EJ
    Adv Perit Dial; 1991; 7():285-7. PubMed ID: 1680447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
    Allegra V; Martimbianco L; Vasile A
    Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous administration of epoetin in haemodialysis patients.
    De Vos JY; Upsing L
    EDTNA ERCA J; 2003; 29(3):156-9. PubMed ID: 14552092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions for erythropoietin-resistant anaemia in dialysis patients.
    Badve SV; Beller EM; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006861. PubMed ID: 23979995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in intravenous and subcutaneous application of recombinant human erythropoietin: a multicenter trial.
    Schaller R; Sperschneider H; Thieler H; Dutz W; Hans S; Voigt D; Marx M; Engelmann J; Schöter KH; Scigalla P
    Artif Organs; 1994 Aug; 18(8):552-8. PubMed ID: 7993190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The practical aspects of therapy with rHuEPO.
    Spinowitz B
    Am J Nephrol; 1990; 10 Suppl 2():24-8. PubMed ID: 2260614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous versus intravenous administration of erythropoietin improves its efficiency for the treatment of anaemia in haemodialysis patients.
    Albitar S; Meulders Q; Hammoud H; Soutif C; Bouvier P; Pollini J
    Nephrol Dial Transplant; 1995; 10 Suppl 6():40-3. PubMed ID: 8524493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human erythropoietin: physiology, pathophysiology of anemia in renal failure, and economic aspects related to dosing.
    Besarab A
    Am J Nephrol; 1990; 10 Suppl 2():2-6. PubMed ID: 2260613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.
    Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF
    Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Maintenance therapy on the anemia in continuous ambulatory peritoneal dialysis (CAPD) patients using subcutaneous administration of recombinant human erythropoietin fortnightly--a multicenter trial].
    Kubota M; Kawaguchi Y; Nomoto Y; Tsuchida H; Nihei H; Kubo K; Omori Y; Babazono T; Ogura Y; Hara S
    Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1081-90. PubMed ID: 8230819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in haemodialysis patients.
    Lui SF; Wong KC; Li PK; Lai KN
    Am J Nephrol; 1992; 12(1-2):55-60. PubMed ID: 1415366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of dialysis factors and route of administration on response of hemodialysis patients to recombinant human erythropoietin.
    Besarab A; Besarab FM; Miller D
    ASAIO Trans; 1991; 37(3):M181-2. PubMed ID: 1751101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S; Safárová R; Horácková M; Herink J; Rychlík I; Bahbouh R; Půtová I
    Cas Lek Cesk; 2001 Apr; 140(7):209-13. PubMed ID: 11374225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weekly subcutaneous erythropoietin maintains hematocrit in chronic hemodialysis patients.
    Parker KP; Sands JM
    J Am Soc Nephrol; 1993 Apr; 3(10):1717-8. PubMed ID: 8318688
    [No Abstract]   [Full Text] [Related]  

  • 39. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
    Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
    Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RBC improved survival due to recombinant human erythropoietin explains effectiveness of less frequent, low dose subcutaneous therapy.
    Schwartz AB; Kahn SB; Kelch B; Kim KE; Pequignot E
    Clin Nephrol; 1992 Nov; 38(5):283-9. PubMed ID: 1451342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.